ASX - By Stock
|
SP1 |
Re:
CFO Liz Warrel resigned
|
|
trader1221
|
24 |
7.4K |
0 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
24
|
7.4K
|
0
|
|
ASX - By Stock
|
SP1 |
FY2022 annual report
|
|
trader1221
|
15 |
6.8K |
25 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
15
|
6.8K
|
25
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Malaysian Operating Licence Renewed
|
|
trader1221
|
101 |
39K |
1 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
101
|
39K
|
1
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Malaysian Operating Licence Renewed
|
|
trader1221
|
101 |
39K |
3 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
101
|
39K
|
3
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Malaysian Operating Licence Renewed
|
|
trader1221
|
101 |
39K |
3 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
101
|
39K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
trader1221
|
1.7K |
561K |
1 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
1.7K
|
561K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
trader1221
|
1.7K |
561K |
2 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
1.7K
|
561K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
trader1221
|
1.7K |
561K |
7 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
1.7K
|
561K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
ISX Financial
|
|
trader1221
|
1.7K |
561K |
7 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
1.7K
|
561K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
trader1221
|
17K |
6.6M |
10 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
17K
|
6.6M
|
10
|
|
ASX - By Stock
|
VUL |
Re:
Ann: Vulcan responds to disinformation in online report
|
|
trader1221
|
252 |
91K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
252
|
91K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Demerger Complete - EU/UK/US Subsidiaries
|
|
trader1221
|
581 |
169K |
0 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
581
|
169K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Demerger Complete - EU/UK/US Subsidiaries
|
|
trader1221
|
581 |
169K |
0 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
581
|
169K
|
0
|
|
ASX - By Stock
|
VUL |
Re:
Ann: Trading Halt
|
|
trader1221
|
31 |
18K |
20 |
27/10/21 |
27/10/21 |
ASX - By Stock
|
31
|
18K
|
20
|
|
ASX - By Stock
|
SYR |
Re:
new Covid variant worse than Delta now in Mozambique
|
|
trader1221
|
25 |
6.9K |
3 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
25
|
6.9K
|
3
|
|
ASX - By Stock
|
SYR |
Re:
new Covid variant worse than Delta now in Mozambique
|
|
trader1221
|
25 |
6.9K |
0 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
25
|
6.9K
|
0
|
|
ASX - By Stock
|
SYR |
Re:
new Covid variant worse than Delta now in Mozambique
|
|
trader1221
|
25 |
6.9K |
2 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
25
|
6.9K
|
2
|
|
ASX - By Stock
|
SYR |
Re:
new Covid variant worse than Delta now in Mozambique
|
|
trader1221
|
25 |
6.9K |
3 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
25
|
6.9K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Demerger of European Businesses
|
|
trader1221
|
589 |
156K |
0 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
589
|
156K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Open letter to Mr Longo regarding ASX investigation and ASIC litigation of ISX and its CEO John Karantzis
|
|
trader1221
|
508 |
155K |
4 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
508
|
155K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2021 Full Year Financial Results Webcast
|
|
trader1221
|
195 |
64K |
6 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
195
|
64K
|
6
|
|
ASX - By Stock
|
SP1 |
Re:
Open letter to Mr Longo regarding ASX investigation and ASIC litigation of ISX and its CEO John Karantzis
|
|
trader1221
|
508 |
155K |
10 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
508
|
155K
|
10
|
|
ASX - By Stock
|
SP1 |
Re:
Open letter to Mr Longo regarding ASX investigation and ASIC litigation of ISX and its CEO John Karantzis
|
|
trader1221
|
508 |
155K |
4 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
508
|
155K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
Round 2 ISX vs ASX
|
|
trader1221
|
1.9K |
655K |
3 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
1.9K
|
655K
|
3
|
|
ASX - By Stock
|
SYR |
Re:
Sovereign risk and synthetic graphite
|
|
trader1221
|
9 |
4.3K |
2 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
9
|
4.3K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
trader1221
|
317 |
155K |
20 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
317
|
155K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
trader1221
|
796 |
393K |
12 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
393K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
trader1221
|
192 |
86K |
42 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
192
|
86K
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
trader1221
|
125 |
55K |
6 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
125
|
55K
|
6
|
|
ASX - By Stock
|
SP1 |
Re:
Summary and timeline of ASX treatment of ISX
|
|
trader1221
|
232 |
56K |
7 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
232
|
56K
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
ISX CEO - JOHN KARANTZIS v FAIRFAX MEDIA PUBLICATIONS (Mr Joe Aston)
|
|
trader1221
|
884 |
309K |
9 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
884
|
309K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trader1221
|
13K |
4.9M |
9 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
trader1221
|
572 |
250K |
7 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
572
|
250K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
trader1221
|
572 |
250K |
3 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
572
|
250K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
trader1221
|
572 |
250K |
11 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
572
|
250K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
trader1221
|
572 |
250K |
19 |
04/12/20 |
04/12/20 |
ASX - By Stock
|
572
|
250K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
trader1221
|
416 |
130K |
2 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
416
|
130K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trader1221
|
13K |
4.9M |
4 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trader1221
|
13K |
4.9M |
54 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
54
|
|
ASX - By Stock
|
MSB |
Re:
AGM Discussion
|
|
trader1221
|
254 |
100K |
4 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
254
|
100K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
trader1221
|
811 |
332K |
1 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
811
|
332K
|
1
|
|
ASX - By Stock
|
SP1 |
Re:
TAS Ready for Go-Live - NSX
|
|
trader1221
|
89 |
33K |
20 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
89
|
33K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trader1221
|
13K |
4.9M |
8 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trader1221
|
13K |
4.9M |
7 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
7
|
|
ASX - By Stock
|
SP1 |
Re:
Round 2 ISX vs ASX
|
|
trader1221
|
1.9K |
655K |
21 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
1.9K
|
655K
|
21
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: ASX Query Letters re ISX suspension & termination by Visa
|
|
trader1221
|
549 |
137K |
0 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
549
|
137K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Something is very wrong. Is anyone watching? Does anyone care? Can this be another government screw-up?
|
|
trader1221
|
292 |
65K |
21 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
292
|
65K
|
21
|
|
ASX - By Stock
|
SP1 |
Re:
Money Laundering VS Suspected Listing Rules Infringement
|
|
trader1221
|
27 |
10K |
20 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
27
|
10K
|
20
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Half Year Accounts
|
|
trader1221
|
245 |
76K |
50 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
245
|
76K
|
50
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trader1221
|
13K |
4.9M |
1 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|